UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Nature communications, 2018-08, Vol.9 (1), p.3196-15, Article 3196

2018

Volltextzugriff (PDF)

Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation

Oncogene, 2014-03, Vol.33 (11), p.1438-1447

2014

Volltextzugriff (PDF)

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

The New England journal of medicine, 2022-06, Vol.386 (25), p.2363-2376

2022

Volltextzugriff (PDF)

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients

Annals of oncology, 2017-08, Vol.28 (8), p.1988-1995

2017

Volltextzugriff (PDF)

In patients with advanced non-small cell lung cancer (NSCLC) LAG-3 is expressed on activated TILs and predicts resistance to PD-1 axis blockers

Annals of oncology, 2017-12, Vol.28, p.xi5-xi5

2017

Volltextzugriff (PDF)

Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration

Antioxidants & redox signaling, 2009-02, Vol.11 (2), p.369-399

2009

Volltextzugriff (PDF)

Pin1 modulates ER[alpha] levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation

Oncogene, 2014-03, Vol.33 (11), p.1438

2014

Volltextzugriff (PDF)

Abstract P3-06-25: PTEN mRNA positivity using in situ measurements is associated with better outcome in Tamoxifen treated breast cancer patients

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P3-P3-06-25

2012

Volltextzugriff (PDF)

Abstract P2-09-18: Multiplexed (18-Plex) measurement of protein targets in trastuzumab-treated patients using imaging mass cytometry

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-09-18

2018

Volltextzugriff (PDF)

Abstract P3-07-06: Objective measurement of HER2 (ERBB2) intracellular and extracellular domain spatial co-localization stratifies benefit from adjuvant trastuzumab

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-07-06

2016

Volltextzugriff (PDF)

The effect of BCG intravesical therapy and recurrence on PDL1 expression in non-invasive bladder cancers

Journal of clinical oncology, 2015, Vol.33 (15_suppl), p.e15504-e15504

2015

Volltextzugriff (PDF)

Primary cerebral lymphomatoid granulomatosis in a HIV-positive patient. Case report

Revista medíca de Chile, 2011-02, Vol.139 (2), p.218-223

2011

Volltextzugriff (PDF)

Programmed death ligand-1 expression in non-small cell lung cancer

Laboratory investigation, 2014-01, Vol.94 (1), p.107-116

2014

Volltextzugriff (PDF)

Programmed death ligand-1 expression in non-small cell lung cancer

Laboratory investigation, 2014-01, Vol.94 (1), p.107-116

2014

Volltextzugriff (PDF)

P3.13D.07 Longitudinal Tumor Microenvironment Analysis in Extensive Stage SCLC Patients Treated with Dual Checkpoint Inhibitor Blockade

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S362-S362

2024

Volltextzugriff (PDF)

Vascular mimicry as a facilitator of melanoma brain metastasis

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.188-188, Article 188

2024

Volltextzugriff (PDF)

Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19

Annals of hepatology, 2015-09, Vol.14 (5), p.710-721

2015

Volltextzugriff (PDF)

1434P Machine learning features derived from spatial interaction of immune cell families are associated with survival in NSCLC patients post-immunotherapy

Annals of oncology, 2023-10, Vol.34, p.S816-S816

2023

Volltextzugriff (PDF)

High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)

Journal for immunotherapy of cancer, 2024-06, Vol.12 (6), p.e009039

2024

Volltextzugriff (PDF)

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Journal for immunotherapy of cancer, 2022-08, Vol.10 (8), p.e004757

2022

Volltextzugriff (PDF)

EP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S543-S544

2024

Volltextzugriff (PDF)

P1.04-23 Characterizing the Tumor Immune Microenvironment of Non-Small Cell Lung Carcinoma in People Living with HIV Using Imaging Mass Cytometry

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S448-S448

2019

Volltextzugriff (PDF)

P15.04 A Phase I/IB Trial of Pembrolizumab and Trametinib Focused on Advanced KRAS Mutant Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S345-S345

2021

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(43)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients

In patients with advanced non-small cell lung cancer (NSCLC) LAG-3 is expressed on activated TILs and predicts resistance to PD-1 axis blockers

Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration

Pin1 modulates ER[alpha] levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation

Abstract P3-06-25: PTEN mRNA positivity using in situ measurements is associated with better outcome in Tamoxifen treated breast cancer patients

Abstract P2-09-18: Multiplexed (18-Plex) measurement of protein targets in trastuzumab-treated patients using imaging mass cytometry

Abstract P3-07-06: Objective measurement of HER2 (ERBB2) intracellular and extracellular domain spatial co-localization stratifies benefit from adjuvant trastuzumab

The effect of BCG intravesical therapy and recurrence on PDL1 expression in non-invasive bladder cancers

Primary cerebral lymphomatoid granulomatosis in a HIV-positive patient. Case report

Programmed death ligand-1 expression in non-small cell lung cancer

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade

Programmed death ligand-1 expression in non-small cell lung cancer

P3.13D.07 Longitudinal Tumor Microenvironment Analysis in Extensive Stage SCLC Patients Treated with Dual Checkpoint Inhibitor Blockade

Vascular mimicry as a facilitator of melanoma brain metastasis

Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19

1434P Machine learning features derived from spatial interaction of immune cell families are associated with survival in NSCLC patients post-immunotherapy

High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Strategies to design clinical studies to identify predictive biomarkers in cancer research

EP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer

P1.04-23 Characterizing the Tumor Immune Microenvironment of Non-Small Cell Lung Carcinoma in People Living with HIV Using Imaging Mass Cytometry

P15.04 A Phase I/IB Trial of Pembrolizumab and Trametinib Focused on Advanced KRAS Mutant Non-Small Cell Lung Cancer

Suchergebnisse filtern